Lederer & Associates Investment Counsel’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.83M | Sell |
11,162
-197
| -2% | -$45.9K | 1.87% | 12 |
|
|
2026
Q1 | $2.78M | Sell |
11,359
-1,897
| -14% | -$442K | 1.97% | 10 |
|
|
2025
Q4 | $2.74M | Sell |
13,256
-28
| -0.2% | -$5.54K | 1.84% | 12 |
|
|
2025
Q3 | $2.46M | Sell |
13,284
-406
| -3% | -$69.6K | 1.6% | 14 |
|
|
2025
Q2 | $2.09M | Sell |
13,690
-580
| -4% | -$89.2K | 1.38% | 19 |
|
|
2025
Q1 | $2.37M | Buy |
14,270
+105
| +0.7% | +$16.4K | 1.73% | 12 |
|
|
2024
Q4 | $2.05M | Buy |
14,165
+26
| +0.2% | +$4.03K | 1.43% | 16 |
|
|
2024
Q3 | $2.29M | Sell |
14,139
-142
| -1% | -$22.6K | 1.61% | 13 |
|
|
2024
Q2 | $2.09M | Sell |
14,281
-1,490
| -9% | -$222K | 1.51% | 17 |
|
|
2024
Q1 | $2.5M | Sell |
15,771
-51
| -0.3% | -$8.12K | 1.73% | 13 |
|
|
2023
Q4 | $2.48M | Sell |
15,822
-120
| -0.8% | -$18.4K | 1.84% | 13 |
|
|
2023
Q3 | $2.48M | Sell |
15,942
-341
| -2% | -$56.3K | 1.97% | 11 |
|
|
2023
Q2 | $2.69M | Sell |
16,283
-137
| -0.8% | -$22.1K | 2.03% | 10 |
|
|
2023
Q1 | $2.54M | Sell |
16,420
-101
| -0.6% | -$16.3K | 1.96% | 8 |
|
|
2022
Q4 | $2.92M | Sell |
16,521
-331
| -2% | -$57.2K | 2.39% | 5 |
|
|
2022
Q3 | $2.75M | Sell |
16,852
-224
| -1% | -$37.9K | 2.33% | 7 |
|
|
2022
Q2 | $3.03M | Sell |
17,076
-2,142
| -11% | -$382K | 2.34% | 7 |
|
|
2022
Q1 | $3.41M | Sell |
19,218
-185
| -1% | -$31.5K | 2.09% | 8 |
|
|
2021
Q4 | $3.32M | Buy |
19,403
+9
| +0% | +$1.47K | 1.92% | 11 |
|
|
2021
Q3 | $3.13M | Buy |
19,394
+167
| +0.9% | +$28.5K | 2.02% | 11 |
|
|
2021
Q2 | $3.17M | Sell |
19,227
-424
| -2% | -$70.2K | 2.11% | 12 |
|
|
2021
Q1 | $3.23M | Buy |
19,651
+292
| +2% | +$47.2K | 2.28% | 6 |
|
|
2020
Q4 | $3.05M | Sell |
19,359
-95
| -0.5% | -$14K | 2.34% | 7 |
|
|
2020
Q3 | $2.9M | Buy |
19,454
+324
| +2% | +$47.9K | 2.41% | 6 |
|
|
2020
Q2 | $2.69M | Buy |
19,130
+38
| +0.2% | +$5.54K | 2.51% | 7 |
|
|
2020
Q1 | $2.5M | Sell |
19,092
-1,062
| -5% | -$151K | 2.83% | 5 |
|
|
2019
Q4 | $2.94M | Buy |
20,154
+129
| +0.6% | +$17.5K | 2.55% | 5 |
|
|
2019
Q3 | $2.59M | Buy |
20,025
+210
| +1% | +$27.7K | 2.48% | 6 |
|
|
2019
Q2 | $2.76M | Buy |
19,815
+55
| +0.3% | +$7.61K | 2.53% | 5 |
|
|
2019
Q1 | $2.76M | Buy |
19,760
+25
| +0.1% | +$3.35K | 2.57% | 5 |
|
|
2018
Q4 | $2.55M | Buy |
19,735
+1,725
| +10% | +$241K | 2.72% | 3 |
|
|
2018
Q3 | $2.49M | Buy |
18,010
+645
| +4% | +$85.7K | 2.1% | 11 |
|
|
2018
Q2 | $2.11M | Sell |
17,365
-120
| -0.7% | -$15K | 1.9% | 15 |
|
|
2018
Q1 | $2.24M | Sell |
17,485
-210
| -1% | -$28.4K | 2.02% | 11 |
|
|
2017
Q4 | $2.47M | Sell |
17,695
-2,492
| -12% | -$347K | 2.21% | 9 |
|
|
2017
Q3 | $2.63M | Buy |
20,187
+120
| +0.6% | +$15.9K | 2.5% | 6 |
|
|
2017
Q2 | $2.65M | Buy |
20,067
+1,225
| +7% | +$156K | 2.56% | 4 |
|
|
2017
Q1 | $2.35M | Buy |
18,842
+25
| +0.1% | +$2.99K | 2.2% | 7 |
|
|
2016
Q4 | $2.17M | Buy |
+18,817
| New | +$2.17M | 2.15% | 9 |
|
|
2015
Q3 | $1.79M | Sell |
19,144
-206
| -1% | -$19.9K | 1.99% | 17 |
|
|
2015
Q2 | $1.89M | Buy |
19,350
+385
| +2% | +$38.6K | 1.94% | 17 |
|
|
2015
Q1 | $1.91M | Buy |
18,965
+710
| +4% | +$72.2K | 1.86% | 18 |
|
|
2014
Q4 | $1.91M | Buy |
+18,255
| New | +$1.92M | 1.89% | 20 |
|
Other funds holding JNJ
AACR
Lederer & Associates Investment Counsel's JNJ Position: Q2 2026 in Review
Lederer & Associates Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $45.9K and leaving 11,162 shares worth $2.83M. The position accounts for 1.87% of the portfolio, ranked #12.
Lederer & Associates Investment Counsel first reported a position in JNJ in Q4 2014 and has held it in 43 quarters since. The position peaked at $3.41M in Q1 2022. 2,235 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Lederer & Associates Investment Counsel held 11,162 shares of Johnson & Johnson worth $2.83M as of Q2 2026.
- Lederer & Associates Investment Counsel sold 197 Johnson & Johnson shares in Q2 2026, an estimated $45.9K.
- Johnson & Johnson made up 1.87% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #12 holding.
- Lederer & Associates Investment Counsel first reported a position in Johnson & Johnson in Q4 2014 and has held it in 43 quarters since.
- Lederer & Associates Investment Counsel's Johnson & Johnson position peaked at $3.41M in Q1 2022.
- 2,235 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.